Focal Dystonia is indicated by sustained or intermittent muscle contraction causing atypical movements or postures on a specific part of the body. The project aims to use botulinum toxin (BoNT) for managing focal dystonia by applying it to target muscles so as to create local atrophy. This project is in collaboration with IMMM in Germany.
Participant/ Christos quote
Dr Christos Ioannou